Dransfield I, Cabañas C, Barrett J, Hogg N
Macrophage Laboratory, Imperial Cancer Research Fund, London, England.
J Cell Biol. 1992 Mar;116(6):1527-35. doi: 10.1083/jcb.116.6.1527.
The leukocyte integrins (CD11/CD18 or beta 2-type integrins) are expressed exclusively on leukocytes and participate in many adhesion-dependent functions (Arnaout, M.A. 1990. Blood. 75:1037-1050; Springer, T. A. 1990. Nature. (Lond.) 346:425-434; Dustin, M. L., and T. S. Springer. 1991. Annu. Rev. Immunol. 9:27-66). The avidity of leukocyte integrin binding to their ligands or counter-receptors is dependent upon response to intracellular signals (Wright, S. D., and B. C. Meyer. 1986. J. Immunol. 136:1759-1764; Dustin, M. A., and T. S. Springer. 1989. Nature (Lond.). 341:619-624). We have investigated the effects of a novel mAb (mAb 24) which defines a leukocyte integrin alpha subunit epitope that is Mg(2+)-dependent and may be used as a "reporter" of the activation state of these receptors (Dransfield, I., and N. Hogg. 1989. EMBO (Eur. Mol. Biol. Organ) J. 8:3759-3765; Dransfield, I., A.-M. Buckle, and N. Hogg. 1990. Immunol. Rev. 114:29-44; Dransfield, I., C. Cabañas, A. Craig, and N. Hogg. 1992. J. Cell Biol.) Data is presented to show that this mAb inhibits monocyte-dependent, antigen-specific T cell proliferation and IL-2-activated natural killer cell assays which are both dependent on lymphocyte function-associated antigen-1 (LFA-1), and complement receptor type 3 (CR3)-mediated neutrophil chemotaxis to f-Met-Leu-Phe. This inhibitory effect is not caused by the prevention of receptor/ligand binding because LFA-1/ICAM-1, LFA-1/ICAM-2,3 and CR3/iC3b interactions are, under activating conditions, promoted rather than blocked by mAb 24. As it does not interfere with mitogen-stimulated T cell proliferation, it is unlikely that mAb 24 transduces a "negative" or antiproliferative signal to the T cells to which it is bound. Using a model system of transient activation of LFA-1, we have found that mAb 24 prevents "deadhesion" of receptor/ligand pairs, possibly locking leukocyte integrins in an "active" conformation. It is speculated that inhibition of leukocyte integrin function by this mAb reflects the necessity for dynamic leukocyte integrin/ligand interactions.
白细胞整合素(CD11/CD18或β2型整合素)仅在白细胞上表达,并参与许多依赖黏附的功能(阿尔纳乌特,M.A. 1990年。《血液》。75:1037 - 1050;斯普林格,T.A. 1990年。《自然》(伦敦)。346:425 - 434;达斯汀,M.L.,和T.S.斯普林格。1991年。《免疫学年度评论》。9:27 - 66)。白细胞整合素与其配体或反受体结合的亲和力取决于对细胞内信号的反应(赖特,S.D.,和B.C.迈耶。1986年。《免疫学杂志》。136:1759 - 1764;达斯汀,M.A.,和T.S.斯普林格。1989年。《自然》(伦敦)。341:619 - 624)。我们研究了一种新型单克隆抗体(单克隆抗体24)的作用,该抗体定义了一个依赖镁离子的白细胞整合素α亚基表位,可用作这些受体激活状态的“报告分子”(德兰斯菲尔德,I.,和N.霍格。1989年。《欧洲分子生物学组织杂志》。8:3759 - 3765;德兰斯菲尔德,I.,A.-M.巴克尔,和N.霍格。1990年。《免疫学评论》。114:29 - 44;德兰斯菲尔德,I.,C.卡瓦尼亚斯,A.克雷格,和N.霍格。1992年。《细胞生物学杂志》)。数据表明,这种单克隆抗体抑制单核细胞依赖性、抗原特异性T细胞增殖以及IL - 2激活的自然杀伤细胞检测,这两种检测都依赖淋巴细胞功能相关抗原 - 1(LFA - 1),以及补体受体3(CR3)介导的中性粒细胞对f - 甲硫氨酰 - 亮氨酰 - 苯丙氨酸的趋化作用。这种抑制作用不是由阻止受体/配体结合引起的,因为在激活条件下,LFA - 1/细胞间黏附分子 - 1(ICAM - 1)、LFA - 1/ICAM - 2、3和CR3/iC3b相互作用是被单克隆抗体24促进而不是阻断。由于它不干扰有丝分裂原刺激的T细胞增殖,单克隆抗体24不太可能向其结合的T细胞转导“负”或抗增殖信号。使用LFA - 1瞬时激活的模型系统,我们发现单克隆抗体24阻止受体/配体对的“去黏附”,可能将白细胞整合素锁定在“活性”构象。据推测,这种单克隆抗体对白细胞整合素功能的抑制反映了动态白细胞整合素/配体相互作用的必要性。